Financial Proceeds - The net proceeds from the rights issue completed on May 8, 2024, amounted to approximately HKD 77.9 million[3] - Of the net proceeds, HKD 70 million is allocated for repaying loans and other payables, with the remaining HKD 7.9 million used for general working capital[4] - As of the announcement date, HKD 70 million of the net proceeds remains unutilized, with expected utilization dates in September 2026 and October 2027[4] Stock Options - The number of stock options available for grant under the stock option plan as of January 1, 2024, was 18,911,563 options, which was adjusted to 1,891,156 options after a share consolidation[5] - The total number of shares available for issuance under the stock option plan is 1,891,156 shares, representing approximately 0.93% of the total issued shares as of March 31, 2025[5]
通达宏泰(02363) - 2025 - 年度业绩